Janus Henderson Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$166M Buy
2,644,539
+645,534
+32% +$45M 0.08% 213
2025
Q4
$133M Sell
1,999,005
-694,760
-26% -$44.9M 0.06% 238
2025
Q3
$181M Buy
2,693,765
+145,719
+6% +$11.5M 0.08% 197
2025
Q2
$222M Buy
2,548,046
+15,038
+0.6% +$1.18M 0.11% 180
2025
Q1
$172M Buy
2,533,008
+2,011,196
+385% +$164M 0.09% 197
2024
Q4
$40.6M Sell
521,812
-34,369
-6% -$2.54M 0.02% 422
2024
Q3
$37.3M Buy
556,181
+31
+0% +$2.55K 0.02% 446
2024
Q2
$63.1M Sell
556,150
-3,368
-0.6% -$426K 0.03% 334
2024
Q1
$77.6M Sell
559,518
-14,999
-3% -$1.89M 0.04% 302
2023
Q4
$71.3M Sell
574,517
-886,978
-61% -$90.6M 0.04% 309
2023
Q3
$136M Buy
1,461,495
+79,556
+6% +$8.97M 0.09% 207
2023
Q2
$178M Buy
1,381,939
+608,423
+79% +$73.6M 0.11% 187
2023
Q1
$89.9M Sell
773,516
-1,889,968
-71% -$212M 0.06% 269
2022
Q4
$302M Sell
2,663,484
-7,108,558
-73% -$780M 0.22% 119
2022
Q3
$787M Buy
9,772,042
+3,676,314
+60% +$311M 0.29% 83
2022
Q2
$454M Sell
6,095,728
-555,384
-8% -$50.7M 0.31% 82
2022
Q1
$851M Sell
6,651,112
-616,552
-8% -$67.4M 0.41% 52
2021
Q4
$976M Sell
7,267,664
-3,195,296
-31% -$459M 0.41% 49
2021
Q3
$1.43B Sell
10,462,960
-1,011,440
-9% -$128M 0.63% 24
2021
Q2
$1.22B Buy
11,474,400
+3,998,492
+53% +$384M 0.52% 27
2021
Q1
$672M Buy
7,475,908
+4,995,320
+201% +$469M 0.31% 80
2020
Q4
$229M Buy
2,480,588
+526,896
+27% +$47M 0.11% 201
2020
Q3
$201M Buy
1,953,692
+262,112
+15% +$27.4M 0.11% 197
2020
Q2
$171M Sell
1,691,580
-1,448,388
-46% -$130M 0.1% 217
2020
Q1
$211M Buy
3,139,968
+796,424
+34% +$49.6M 0.15% 151
2019
Q4
$128M Sell
2,343,544
-881,720
-27% -$41.8M 0.07% 296
2019
Q3
$120M Sell
3,225,264
-777,660
-19% -$30.2M 0.07% 313
2019
Q2
$150M Sell
4,002,924
-1,807,016
-31% -$56.8M 0.08% 273
2019
Q1
$173M Buy
5,809,940
+821,608
+16% +$28.9M 0.1% 247
2018
Q4
$149M Sell
4,988,332
-1,856,556
-27% -$58.9M 0.1% 263
2018
Q3
$245M Sell
6,844,888
-10,924,604
-61% -$339M 0.13% 198
2018
Q2
$422M Sell
17,769,492
-9,895,672
-36% -$210M 0.24% 111
2018
Q1
$513M Sell
27,665,164
-6,994,932
-20% -$103M 0.3% 83
2017
Q4
$497M Sell
34,660,096
-619,204
-2% -$8.05M 0.3% 82
2017
Q3
$432M Buy
35,279,300
+7,964,376
+29% +$141M 0.28% 98
2017
Q2
$500M Buy
27,314,924
+27,288,092
+101,700% +$504M 0.34% 66
2017
Q1
$568K Hold
26,832
﹤0.01% 762
2016
Q4
$401K Buy
+26,832
New +$475K ﹤0.01% 792

Other funds holding DXCM

Janus Henderson Group's DXCM Position: Q1 2026 in Review

Janus Henderson Group increased its DexCom (DXCM) stake by 32% in Q1 2026, buying an estimated $45M and bringing the position to 2,644,539 shares worth $166M. The position accounts for 0.08% of the portfolio, ranked #213.

Janus Henderson Group first reported a position in DXCM in Q4 2016 and has held it in 38 quarters since. The position peaked at $1.43B in Q3 2021. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Janus Henderson Group held 2,644,539 shares of DexCom worth $166M as of Q1 2026.
  • Janus Henderson Group bought 645,534 DexCom shares in Q1 2026, an estimated $45M.
  • DexCom made up 0.08% of Janus Henderson Group's portfolio in Q1 2026, its #213 holding.
  • Janus Henderson Group first reported a position in DexCom in Q4 2016 and has held it in 38 quarters since.
  • Janus Henderson Group's DexCom position peaked at $1.43B in Q3 2021.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.